Development of morphine-induced tolerance and withdrawal: Involvement of the clock gene mPer2

European Neuropsychopharmacology

Volumn 20, Issue 7, 2010, Pages 509-517

  Perreau Lenz, Stéphanie ^a   Sanchis Segura, Carles ^a   Leonardi Essmann, Fernando ^a   Schneider, Miriam ^a   Spanagel, Rainer ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Clock genes; Mice; Morphine; Per2 gene; Tolerance; Withdrawal

Indexed keywords

CANNABINOID 1 RECEPTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; DELTA OPIATE RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE RECEPTOR; DOPAMINE RECEPTOR 1 ALPHA; MORPHINE; MU OPIATE RECEPTOR; NALOXONE; NEUROPEPTIDE Y; PER1 PROTEIN; PER2 PROTEIN; PREPROENKEPHALIN; PREPROENKEPHALIN 1; PRODYNORPHIN; PROOPIOMELANOCORTIN; PROOPIOMELANOCORTIN 1; TRANSCRIPTION FACTOR CLOCK; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANALGESIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AVERSION; AVOIDANCE BEHAVIOR; CONTROLLED STUDY; DRUG TOLERANCE; GENE EXPRESSION; LATENT PERIOD; LOCOMOTION; MOUSE; NONHUMAN; PLACE PREFERENCE; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WITHDRAWAL SYNDROME;

ANIMALS; AVOIDANCE LEARNING; BRAIN; CONDITIONING, OPERANT; DRUG TOLERANCE; MALE; MICE; MICE, TRANSGENIC; MORPHINE; MORPHINE DEPENDENCE; MUTATION; NALOXONE; NARCOTIC ANTAGONISTS; PAIN MEASUREMENT; PERIOD CIRCADIAN PROTEINS;

EID: 77953357582     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.euroneuro.2010.03.006     Document Type: Article

References (40)

1. Abarca C., Albrecht U., Spanagel R. Cocaine sensitization and reward are under the influence of circadian genes and rhythm. Proc. Natl. Acad. Sci. U.S.A. 2002, 99(13):9026-9030.
2. Aghajanian G.K., Kogan J.H., Moghaddam B. Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study. Brain Res. 1994, 636(1):126-130.
3. Ammon S., Mayer P., Riechert U., Tischmeyer H., Hollt V. Microarray analysis of genes expressed in the frontal cortex of rats chronically treated with morphine and after naloxone precipitated withdrawal. Brain Res. Mol. Brain Res. 2003, 112(1-2):113-125.
4. Ammon-Treiber S., Hollt V. Morphine-induced changes of gene expression in the brain. Addict. Biol. 2005, 10(1):81-89.
5. Andretic R., Chaney S., Hirsh J. Requirement of circadian genes for cocaine sensitization in Drosophila. Science 1999, 285(5430):1066-1068.
6. Argyle E. Circadian variation of the lethality of methadone. Nature 1973, 242(5396):332.
7. Aton S.J., Herzog E.D. Come together, right...Now: synchronization of rhythms in a Mammalian circadian clock. Neuron 2005, 48(4):531-534.
8. Azar M.R., Jones B.C., Schulteis G. Conditioned place aversion is a highly sensitive index of acute opioid dependence and withdrawal. Psychopharmacology 2003, 170(1):42-50.
9. Caille S., Espejo E.F., Koob G.F., Stinus L. Dorsal and median raphe serotonergic system lesion does not alter the opiate withdrawal syndrome. Pharmacol. Biochem. Behav. 2002, 72(4):979-986.
10. Cutler D.J., Mundey M.K., Mason R. Electrophysiological effects of opioid receptor activation on Syrian hamster suprachiasmatic nucleus neurones in vitro. Brain Res. Bull. 1999, 50(2):119-125.
11. Dardente H., Cermakian N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 2007, 24(2):195-213.
12. Falcon E., McClung C.A. A role for the circadian genes in drug addiction. Neuropharmacology 2009, 56(Suppl 1):91-96.
13. Gaveriaux-Ruff C., Kieffer B.L. Opioid receptor genes inactivated in mice: the highlights. Neuropeptides 2002, 36(2-3):62-71.
14. Georges F., Stinus L., Bloch B., Le Moine C. Chronic morphine exposure and spontaneous withdrawal are associated with modifications of dopamine receptor and neuropeptide gene expression in the rat striatum. Eur. J. NeuroSci. 1999, 11(2):481-490.
15. Hampp G., Ripperger J.A., Houben T., Schmutz I., Blex C., Perreau-Lenz S., Brunk I., Spanagel R., Ahnert-Hilger G., Meijer J.H., Albrecht U. Regulation of monoamine oxidase a by circadian-clock components implies clock influence on mood. Curr. Biol. 2008, 18(9):678-683.
16. Kieffer B.L., Gaveriaux-Ruff C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 2002, 66(5):285-306.
17. Ko C.H., Takahashi J.S. Molecular components of the mammalian circadian clock. Hum. Mol. Genet. 2006, 15. Spec No 2 R271-7.
18. Lenox R.H., Frazier T.W. Methadone induced mortality as a function of the circadian cycle. Nature 1972, 239(5372):397-398.
19. Li S.X., Liu L.J., Jiang W.G., Lu L. Morphine withdrawal produces circadian rhythm alterations of clock genes in mesolimbic brain areas and peripheral blood mononuclear cells in rats. J. Neurochem. 2009, 109(6):1668-1679.
20. Lynch W.J., Girgenti M.J., Breslin F.J., Newton S.S., Taylor J.R. Gene profiling the response to repeated cocaine self-administration in dorsal striatum: a focus on circadian genes. Brain Res. 2008, 1213:166-177.
21. Maldonado R., Saiardi A., Valverde O., Samad T.A., Roques B.P., Borrelli E. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors. Nature 1997, 388(6642):586-589.
22. Manev H., Uz T. Clock genes: influencing and being influenced by psychoactive drugs. Trends Pharmacol. Sci. 2006, 27(4):186-189.
23. McClung C.A. The molecular mechanisms of morphine addiction. Rev. Neurosci. 2006, 17(4):393-402.
24. Oyefeso A., Sedgwick P., Ghodse H. Subjective sleep-wake parameters in treatment-seeking opiate addicts. Drug Alcohol Depend. 1997, 48(1):9-16.
25. Perreau-Lenz S., Spanagel R. The effects of drugs of abuse on clock genes. Drug News Perspect. 2008, 21(4):211-217.
26. Perreau-Lenz S., Zghoul T., De Fonseca F.R., Spanagel R., Bilbao A. Circadian regulation of central ethanol sensitivity by the mPer2 gene. Addict. Biol. 2009, 14(3):253-259.
27. Pothos E., Rada P., Mark G.P., Hoebel B.G. Dopamine microdialysis in the nucleus accumbens during acute and chronic morphine, naloxone-precipitated withdrawal and clonidine treatment. Brain Res. 1991, 566(1-2):348-350.
28. Raymond R.C., Warren M., Morris R.W., Leikin J.B. Periodicity of presentations of drugs of abuse and overdose in an emergency department. J. Toxicol. Clin. Toxicol. 1992, 30(3):467-478.
29. Reinberg A., Clench J., Aymard N., Galliot M., Bourdon R., Gervais P., Abulker C., Dupont J. Variations circadiennes des effets de l'ethanol et de l'ethanolamie chez l'homme adulte sain. Etude chronopharmacologique. J. Physiol. 1975, 70:435-456.
30. Robledo P., Berrendero F., Ozaita A., Maldonado R. Advances in the field of cannabinoid-opioid cross-talk. Addict. Biol. 2008, 13(2):213-224.
31. Sepulveda M.J., Hernandez L., Rada P., Tucci S., Contreras E. Effect of precipitated withdrawal on extracellular glutamate and aspartate in the nucleus accumbens of chronically morphine-treated rats: an in vivo microdialysis study. Pharmacol. Biochem. Behav. 1998, 60(1):255-262.
32. Simonin F., Valverde O., Smadja C., Slowe S., Kitchen I., Dierich A., Le Meur M., Roques B.P., Maldonado R., Kieffer B.L. Disruption of the kappa-opioid receptor gene in mice enhances sensitivity to chemical visceral pain, impairs pharmacological actions of the selective kappa-agonist U-50, 488H and attenuates morphine withdrawal. Embo J. 1998, 17(4):886-897.
33. Sinnett E.R., Morris J.B. Temporal patterns of the use of non-prescribed drugs. Percept. Mot. Skills 1977, 45(3 Pt 2):1239-1245.
34. Spanagel R., Almeida O.F., Bartl C., Shippenberg T.S. Endogenous kappa-opioid systems in opiate withdrawal: role in aversion and accompanying changes in mesolimbic dopamine release. Psychopharmacology 1994, 115(1-2):121-127.
35. Spanagel R., Pendyala G., Abarca C., Zghoul T., Sanchis-Segura C., Magnone M.C., Lascorz J., Depner M., Holzberg D., Soyka M., Schreiber S., Matsuda F., Lathrop M., Schumann G., Albrecht U. The clock gene Per2 influences the glutamatergic system and modulates alcohol consumption. Nat. Med. 2005, 11(1):35-42.
36. Stinus L., Robert C., Karasinski P., Limoge A. Continuous quantitative monitoring of spontaneous opiate withdrawal: locomotor activity and sleep disorders. Pharmacol. Biochem. Behav. 1998, 59(1):83-89.
37. Vengeliene V., Leonardi-Essmann F., Perreau-Lenz S., Gebicke-Haerter P., Drescher K., Gross G., Spanagel R. The dopamine D3 receptor plays an essential role in alcohol-seeking and relapse. FASEB J. 2006, 20(13):2223-2233.
38. Wang X.W., Wang Y., Xin H., Liu Y., Wang Y., Zheng H., Jiang Z., Wan C., Wang Z., Ding J.M. Altered expression of circadian clock gene, mPer1, in mouse brain and kidney under morphine dependence and withdrawal. J. Circ. Rhythms 2006, 4:9.
39. Yoshida M., Ohdo S., Takane H., Tomiyoshi Y., Matsuo A., Yukawa E., Higuchi S. Chronopharmacology of analgesic effect and its tolerance induced by morphine in mice. J. Pharmacol. Exp. Ther. 2003, 305(3):1200-1205.
40. Zheng B., Larkin D.W., Albrecht U., Sun Z.S., Sage M., Eichele G., Lee C.C., Bradley A. The mPer2 gene encodes a functional component of the mammalian circadian clock. Nature 1999, 400(6740):169-173.